ESOPMay 1, 2026, 04:31 PM
Dianthus Therapeutics Grants 135,000 Stock Options to New Hires
AI Summary
Dianthus Therapeutics, Inc. granted inducement equity awards on May 1, 2026, to six newly-hired, non-executive employees. These grants, approved by the Company's independent Compensation Committee, consist of non-qualified stock options to purchase an aggregate of 135,000 shares of common stock. The options have a 10-year term and an exercise price of $87.42 per share, vesting 25% on the first anniversary and in equal monthly installments for the following 36 months.
Key Highlights
- Granted equity awards to six newly-hired, non-executive employees.
- Total of 135,000 shares of common stock granted via non-qualified stock options.
- Exercise price set at $87.42 per share.
- Options have a 10-year term.
- Vesting schedule: 25% on first anniversary, then equal monthly installments for 36 months.
Price Impact
More from DNTH